Incyte Corp

INCY: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
!VlLOCK|b^LOCK|b^$qX^

Incyte Earnings: Opzelura Settlement and Latarcibart Improve Outlook Ahead of Jakafi Patent Loss

Incyte reported total net sales of $1.49 billion in the second quarter, an increase of 40% from the prior year. Management raised its 2026 total net sales guidance by 7% at the midpoint of its previous outlook.

Sponsor Center